American Capital Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28 Hold
2
﹤0.01% 1160
2026
Q1
$12 Hold
2
﹤0.01% 1139
2025
Q4
$15 Hold
2
﹤0.01% 1078
2025
Q3
$22 Hold
2
﹤0.01% 1004
2025
Q2
$20 Hold
2
﹤0.01% 861
2025
Q1
$30 Hold
2
﹤0.01% 795
2024
Q4
$30 Hold
2
﹤0.01% 461
2024
Q3
$39 Hold
2
﹤0.01% 464
2024
Q2
$29 Sell
2
-79,144
-100% -$1.57M ﹤0.01% 427
2024
Q1
$1.86M Buy
79,146
+79,144
+3,957,200% +$1.36M 1.62% 13
2023
Q4
$29 Buy
+2
New +$27 ﹤0.01% 427

Other funds holding OGN

American Capital Advisory's OGN Position: Q2 2026 in Review

American Capital Advisory held its Organon & Co (OGN) position steady in Q2 2026 at 2 shares worth $28. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

American Capital Advisory first reported a position in OGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.86M in Q1 2024. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • American Capital Advisory held 2 shares of Organon & Co worth $28 as of Q2 2026.
  • American Capital Advisory left its Organon & Co share count unchanged in Q2 2026.
  • Organon & Co made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #1160 holding.
  • American Capital Advisory first reported a position in Organon & Co in Q4 2023 and has held it in 11 quarters since.
  • American Capital Advisory's Organon & Co position peaked at $1.86M in Q1 2024.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.